Clinical studies have shown that elevated BTLA expression on circulating or tumor-infiltrating B cells correlates with poor prognosis in several cancers, including hepatocellular carcinoma and non-small cell lung cancer [4]. The gene discussed is BTLA; the disease is hepatocellular carcinoma.